Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Receivables (2023 - 2025)

Upstream Bio (UPB) has 3 years of Change in Receivables data on record, last reported at -$254000.0 in Q3 2025.

  • For Q3 2025, Change in Receivables fell 361.86% year-over-year to -$254000.0; the TTM value through Sep 2025 reached $76000.0, down 77.78%, while the annual FY2024 figure was $515000.0, 264.01% up from the prior year.
  • Change in Receivables reached -$254000.0 in Q3 2025 per UPB's latest filing, down from $371000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $640000.0 in Q1 2024 and bottomed at -$254000.0 in Q3 2025.
  • Average Change in Receivables over 3 years is $52250.0, with a median of -$20500.0 recorded in 2024.
  • The widest YoY moves for Change in Receivables: up 262.72% in 2025, down 361.86% in 2025.
  • A 3-year view of Change in Receivables shows it stood at -$167000.0 in 2023, then skyrocketed by 103.59% to $6000.0 in 2024, then plummeted by 4333.33% to -$254000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$254000.0 in Q3 2025, $371000.0 in Q2 2025, and -$47000.0 in Q1 2025.